Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Hospira Inc. is recalling Carboplatin Injection vials because visible particles are embedded in the glass neck, posing a risk of dislodging into the solution.
Hospira Inc. is recalling Methotrexate Injection vials because visible particles embedded in the glass neck may dislodge into the solution.
Hospira Inc. is recalling Paclitaxel Injection vials because visible particles are embedded in the glass at the neck. The particles may dislodge into the solution.
Hospira is recalling 210 vials of Cytarabine Injection because visible particles embedded in the glass neck may dislodge into the solution.
Sandoz Incorporated is recalling specific lots of Pramipexole Dihydrochloride Tablets because stability testing revealed an out-of-specification impurity.
Sandoz Incorporated is recalling Pramipexole Dihydrochloride Tablets, 0.25 mg, because an out-of-specification result for a known impurity occurred during stability testing.
Apace KY LLC is recalling 81,516 bottles of Enalapril Maleate 5mg tablets because some labels have incomplete NDC numbers and missing strength information.
Medtech Products Inc. is recalling Little Remedies For Tummys Stimulant Laxative Drops because the sennosides ingredient is subpotent.
Apotex Corp. is recalling specific lots of Leflunomide 10 mg tablets because they did not meet potency specifications.
Bracco Diagnostics is recalling 4,870 vials of Multihance injection because aluminum crimp caps may displace during use, compromising sterility.
Island Kinetics is recalling CosMedix Serious Protection SPF 28 Sunscreen due to microbial contamination and mold. Consumers should stop using the product.
GlaxoSmithKline is recalling 1.4 million Ventolin inhalers because the albuterol content may be below specification, potentially failing to deliver the proper metered dose.
Apotex Corp. is recalling 31 bottles of Leflunomide 20 mg tablets because the product did not meet specifications. The recall is nationwide.
Natural Essentials Inc is recalling specific lots of Oasis Age Essential Mouthwash due to contamination with Burkholderia cepacia.
American Health Packaging is recalling 694 cartons of Mercaptopurine Tablets, USP, 50 mg, because the lot failed USP dissolution test requirements.
Hospira Inc. is recalling 56,420 vials of Propofol Injectable Emulsion because a visible particulate was found during inspection.
Capco Custom Packaging is recalling Eco-Dent Sparkling Clean Mint mouth rinse due to contamination with Sphingomonas paucimobilis bacteria.
Galderma is recalling 17,160 bottles of Capex Shampoo because the fluocinolone acetonide content is subpotent. The product was distributed nationwide and in Puerto Rico.
Apotex Corp. is recalling Azelastine Hydrochloride Nasal Solution because tubing used for filling may interact with the nasal formulation.
Bracco Diagnostics is recalling 47,750 vials of Multihance injection due to a potential underfill of the product.
VistaPharm is recalling 73,800 cups of Metoclopramide Oral Solution because the shipper label incorrectly displayed '5 mL x 50' instead of '10 mL x 50'.
The Menz Club, LLC is recalling V Maxx Rx because FDA testing found it contains an unapproved drug analogue.
Noven Pharmaceuticals is recalling 177,900 Daytrana (methylphenidate) patches because the delivery system may be miscalibrated or defective, potentially affecting the removal of the release liner.
Noven Pharmaceuticals is recalling 231,270 Daytrana patches because the release liner may be difficult to remove.
VistaPharm is recalling Xactdose Phenytoin Oral Suspension because defective container lids allow moisture loss, potentially causing viscosity and assay failures.